The results of three important studies have been published in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Jun 19, 2013
0
0
NUS chemists have developed a simple and robust bio-screening method to identify anticancer drug candidates to overcome multidrug resistance (MDR).
Jul 7, 2017
0
1
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information ...
Jun 6, 2012
0
0
Dartmouth researchers and their colleagues have carried out the first total syntheses of certain compounds involved in excessive cell death in leukemia.
Jul 21, 2015
0
9
(Medical Xpress)—Survival rates have increased significantly among patients who received blood stem cell transplants from both related and unrelated donors, according to a study published in the Journal of Clinical Oncology ...
May 29, 2013
0
0
(Medical Xpress)—Researchers at the University of Arkansas have developed a new model system to study a receptor protein that controls cell death in both humans and fruit flies, a discovery that could lead to a better understanding ...
Apr 3, 2013
0
0
Researchers from Lomonosov MSU Faculty of Biology have studied the stages of entosis, a process of cell death when one cell invades the other and is digested inside of it. Entosis could become a new method of destroying cancer ...
Nov 28, 2017
0
0
Every year acute renal failure affects over 13 million people and leads to 1.7 million deaths across the globe.It often develops when an insufficient supply of oxygen reaches the kidneys, a condition called ischemia. Working ...
Jan 28, 2016
0
21
University of Saskatchewan (USask) research, which has been published in Communications Biology, highlights the discovery of the lipid-lowering effects of nesfatin-1-like peptide (NLP). This newly identified peptide—or ...
May 28, 2024
0
8
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that a microRNA called miR-181a dampens signals from the cancer-driving NFκB protein pathway ...
Mar 31, 2016
0
0
